| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |